España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bright Minds Biosciences
DRUG
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$35.33
2.95
9.11%
At close: -
$33.34
-1.99
-5.63%
After Hours: Nov 22, 4:38 PM EDT
Get Report
Comment
Bright Minds Biosciences (DRUG) Forecast
News
Earnings
Bright Minds Biosciences (DRUG) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Bright Minds Biosciences (NASDAQ:DRUG) Stock
Bright Minds Biosciences Stock (NASDAQ: DRUG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 04, 2024
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
Chris Katje
Monday, October 21, 2024
What's Going On With Bright Minds Biosciences Stock?
Adam Eckert
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Firefly Neuroscience and Bright Minds Bioscie...
Benzinga Newsdesk
Bright Minds Biosciences shares are trading h...
Benzinga Newsdesk
Bright Minds Biosciences Announces Collaborat...
Benzinga Newsdesk
Friday, October 18, 2024
Nasdaq Surges Over 100 Points; Schlumberger Reports Mixed Q3 Result
Avi Kapoor
Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results
Avi Kapoor
What's Going On With Bright Minds Biosciences Stock Friday?
Dylan Berman
Bright Minds Biosciences Shares Resume Trade
Benzinga Newsdesk
Bright Minds Biosciences Shares Resume Trade ...
Benzinga Newsdesk
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Dow Falls Over 100 Points; Netflix Posts Upbeat Results
Avi Kapoor
Bright Minds Biosciences Shares Halted To The...
Benzinga Newsdesk
Market-Moving News for October 18th
Benzinga Newsdesk
Bright Minds Biosciences shares are trading h...
Benzinga Newsdesk
Bright Minds Biosciences Announces $35M Priva...
Benzinga Newsdesk
Thursday, October 17, 2024
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis
Juan Spínelli
Wednesday, October 16, 2024
Perceptive Advisors LLC, Joseph Edelman, And ...
Benzinga Newsdesk
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
Avi Kapoor
Bright Minds Biosciences Shares Halted; Stock...
Benzinga Newsdesk
Bright Minds Biosciences Shares Resume Tradin...
Benzinga Newsdesk
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
Avi Kapoor
Bright Minds Biosciences Shares Halted To The...
Benzinga Newsdesk
Firefly Neuroscience Collabs With Bright Mind...
Benzinga Newsdesk
Tuesday, October 15, 2024
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Bright Minds Biosciences Shares Resume Tradin...
Benzinga Newsdesk
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Bright Minds Biosciences Shares Resume Then A...
Benzinga Newsdesk
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Bright Minds Biosciences Shares Resume Trade
Benzinga Newsdesk
Bright Minds Biosciences Shares Halted On Cir...
Benzinga Newsdesk
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, September 23, 2024
'DEA Calls For Massive Increases In Psilocybi...
Benzinga Newsdesk
Thursday, September 12, 2024
Bright Minds Biosciences Announces Phase 2 Cl...
Benzinga Newsdesk
Friday, August 16, 2024
Bright Minds Biosciences Reports Improved Financial Position For Q3 Amid Ongoing R&D Efforts
Juan Spínelli
Tuesday, July 16, 2024
'MDMA Therapy Gets Support From Prominent Res...
Benzinga Newsdesk
Wednesday, June 12, 2024
'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk
Tuesday, May 07, 2024
"FDA Expert Committee Will Review MDMA-Assist...
Benzinga Newsdesk
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Monday, February 12, 2024
'FDA Grants Priority Review Of MDMA-Assisted ...
Benzinga Newsdesk
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
Show More